XLONTHRL
Market cap648mUSD
Dec 24, Last price
83.50GBP
1D
1.58%
1Q
-7.43%
Jan 2017
-26.11%
IPO
-18.54%
Name
Target Healthcare REIT PLC
Chart & Performance
Profile
Target Healthcare REIT provide a range of tailored funding solutions to support operators to increase the provision of modern, purpose-built care homes across the UK.
IPO date
Mar 07, 2013
Employees
0
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 69,551 2.66% | 67,748 6.09% | 63,859 27.77% | |||||||
Cost of revenue | 10,592 | 10,474 | 10,310 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 58,959 | 57,274 | 53,549 | |||||||
NOPBT Margin | 84.77% | 84.54% | 83.86% | |||||||
Operating Taxes | 57,010 | 6 | ||||||||
Tax Rate | 99.54% | 0.01% | ||||||||
NOPAT | 58,959 | 264 | 53,543 | |||||||
Net income | 73,024 -1,211.14% | (6,572) -113.39% | 49,097 11.88% | |||||||
Dividends | (35,244) | (40,274) | (39,785) | |||||||
Dividend yield | 7.24% | 9.04% | 6.13% | |||||||
Proceeds from repurchase of equity | (102,911) | |||||||||
BB yield | 15.85% | |||||||||
Debt | ||||||||||
Debt current | 1,835 | 1,895 | ||||||||
Long-term debt | 227,051 | 231,383 | ||||||||
Deferred revenue | 8,239 | 8,390 | ||||||||
Other long-term liabilities | 240,672 | 18,160 | 25,118 | |||||||
Net debt | (41,704) | 194,227 | 189,366 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 42,345 | 29,665 | 30,392 | |||||||
CAPEX | ||||||||||
Cash from investing activities | 3,417 | (3,553) | (202,633) | |||||||
Cash from financing activities | (22,244) | (45,229) | 185,618 | |||||||
FCF | 781,498 | 58,030 | (172,199) | |||||||
Balance | ||||||||||
Cash | 38,884 | 19,661 | 34,483 | |||||||
Long term investments | 2,820 | 14,998 | 9,429 | |||||||
Excess cash | 38,226 | 31,272 | 40,719 | |||||||
Stockholders' equity | 432,660 | 398,175 | 442,134 | |||||||
Invested Capital | 910,675 | 901,393 | 954,685 | |||||||
ROIC | 6.51% | 0.03% | 6.41% | |||||||
ROCE | 6.21% | 6.32% | 5.57% | |||||||
EV | ||||||||||
Common stock shares outstanding | 620,237 | 620,237 | 599,094 | |||||||
Price | 0.79 9.33% | 0.72 -33.76% | 1.08 -6.07% | |||||||
Market cap | 486,886 9.33% | 445,330 -31.43% | 649,418 18.37% | |||||||
EV | 445,182 | 639,557 | 838,784 | |||||||
EBITDA | 58,959 | 57,274 | 53,549 | |||||||
EV/EBITDA | 7.55 | 11.17 | 15.66 | |||||||
Interest | 10,245 | 9,572 | 6,671 | |||||||
Interest/NOPBT | 17.38% | 16.71% | 12.46% |